Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

HHS Accessibility Requirements for Medical Diagnostic Equipment: What Health Care Providers Need to Know

Client Alert

The U.S. Department of Health and Human Services (HHS), through its Office for Civil Rights, has adopted updated accessibility requirements for medical diagnostic equipment under Section 504 of the Rehabilitation Act.[1] These requirements are intended to reduce barriers to care for individuals with disabilities and to ensure that covered providers offer services in a manner that is accessible and nondiscriminatory.

For health care providers that receive federal financial assistance, including providers participating in Medicare, Medicaid, CHIP, or other HHS-funded programs, the rule creates specific obligations regarding accessible medical diagnostic equipment (MDE), staff preparedness, and program accessibility. In practice, the rule is aimed at ensuring that patients with disabilities can receive routine examinations and diagnostic services using equipment that is accessible and usable.

Key takeaways from the updated rule include the following:

  • The rule adopts accessibility standards for medical diagnostic equipment, including examination tables, examination chairs, weight scales, mammography equipment, and certain radiological equipment.
  • Providers must ensure that their services are accessible in practice, even if a particular office or location does not yet have all required accessible equipment in place. If needed, the provider may need to arrange care at a hospital or another accessible practice location.
  • Covered entities must have qualified staff who can operate accessible equipment and assist patients with transfers and positioning as needed.
  • The rule also strengthens broader disability nondiscrimination protections affecting digital accessibility and other health and human services activities. 

Under the rule, each covered provider that uses examination tables and weight scales must have at least one accessible examination table and one accessible weight scale in place by July 8, 2026. Beyond that baseline requirement, covered providers generally must ensure that at least 10% of each type of medical diagnostic equipment is accessible, with a minimum of one accessible unit. For providers that specialize in treating conditions affecting mobility, such as rehabilitation centers and physical therapy practices, the threshold increases to 20%. 

With the July 8, 2026 compliance deadline now here for HHS-funded recipients, providers should assess current equipment inventories, identify whether accessible examination tables and weight scales are available at each relevant location, review purchasing practices, and train staff on equipment use and patient assistance protocols. Providers that fail to comply may face enforcement risk, including administrative action and potential litigation exposure. 

For many providers, this is not simply an equipment procurement issue. It is also an operational compliance issue that requires coordination across facilities, purchasing, clinical operations, and staff training. Covered entities should consider acting now to confirm that their accessibility practices align with the updated Section 504 requirements. 

For questions regarding the updated MDE accessibility requirements or assistance with compliance and implementation, please contact Vice President and Akron Managing Partner Amanda Waesch at alwaesch@bmdllc.com

[1] 29 U.S.C. §794.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.